GSK · Pharma and healthcare · one day
GSK (GSK): news on Sunday 15 November 2026
News from the 24 hours to Sunday morning, 15 November 2026.
Tone of the day
What the score means. Each score rates how good or bad the news was for the company, from −10 (clearly bad) to +10 (clearly good). 0 is neutral, and anything beyond ±6 is strong and rare. It rates the coverage, not the share price.
Why it scored this way
Coverage leaned positive, led by earnings call commentary pointing to strong growth, a Canadian approval for a hepatitis B therapy and a favourable European regulatory opinion on Bexsero and Talzenna. Other items, such as a former chief executive's new role and a ViiV appointment, were minor.
What drove it
- earnings call
- regulatory approvals
- Bexsero and Talzenna CHMP opinion
Around this day
| Day | Tone | Headlines |
|---|---|---|
| Mon 9 Nov | −3.3 | 3 |
| Tue 10 Nov | +6.3 | 13 |
| Wed 11 Nov | +4.5 | 6 |
| Thu 12 Nov | +4.5 | 12 |
| Fri 13 Nov | +4.2 | 14 |
| Sat 14 Nov | +9.2 | 20 |
| Sun 15 Nov | +7.0 | 6 |
| Mon 16 Nov | +2.5 | 4 |
6 stories · 6 headlines · strongest first
Pharma and healthcare on 15 NovemberFTSE 100 that day| Tone | What the article reported, and why it scored that way | |
|---|---|---|
| GSK earnings call coverage +9.21 headline today · A summary says the earnings call signalled growth despite headwinds. | ||
| +9.2 | Earnings call coverage points to strong growth despite some pressures.</br> | |
| EU committee backs GSK's Bexsero meningitis B booster +9.61 headline today · 12 in all, since 14 November · CHMP backed a Bexsero booster dose and a wider Talzenna indication. | ||
| +8.3 | European regulator backs Bexsero booster and wider Talzenna use. | |
| Canada approves hepatitis B functional-cure therapy +8.31 headline today · Canada has cleared a hepatitis B therapy that is the first to offer a functional cure. | ||
| +8.3 | Canadian approval of first hepatitis B functional-cure treatment, likely GSK's. | |
| Emma Walmsley named HP CEO-designate +0.81 headline today · Former GSK chief Emma Walmsley was named HP chief executive-designate. | ||
| +0.8 | Former GSK chief takes top job at another firm; minor link. | |
| ViiV Healthcare appoints HR business leader +0.51 headline today · Shivani Singh was appointed to an HR role at ViiV Healthcare. | ||
| +0.5 | Routine HR appointment at ViiV, a GSK-controlled business. | |
| GSK share outlook for the week of 16–20 November 0.01 headline today · A preview sets out levels and scenarios for the week. | ||
| 0.0 | Share price outlook piece with scenarios, no clear direction. | |
Each article has its own score. The lines are our own summary; follow the source link to read the article itself.
Follow by email
A short, free morning email on how the news treated GSK: the tone, the stories behind it, and when coverage starts to turn. Launching soon; one click to unsubscribe.